Thorax

New International Study Reports Extension of the Donor Lung Transplantation Window

Retrieved on: 
Tuesday, March 12, 2024
FDA, Surgery, Medical Devices, Hospitals, Health, Clinic, Temperature, UZ Leuven, Transplant, Massachusetts General Hospital, Assistant, Motol University Hospital, Risk, Patient, Transport, Lung transplantation, Surgeon, Thorax, Ice, Dentistry

This milestone publication lays a strong foundation for future clinical applications in organ preservation and transplantation.

Key Points: 
  • This milestone publication lays a strong foundation for future clinical applications in organ preservation and transplantation.
  • For example, presenting a means to better accommodate longer transportation times, overnight bridging, or optimizing case scheduling during the day.
  • During the six-month study period, the LUNGguard® Donor Lung Preservation System was utilized to preserve donor lungs for over 15 hours in 13 separate instances.
  • Longer ischemic times increase the risk of primary graft dysfunction, a serious complication that can occur after lung transplantation.

MEDITWIN Brings Together French Science and Technology Excellence Around Virtual Twins for the Future of Medical Care

Retrieved on: 
Wednesday, January 24, 2024
Data Management, Other Science, Technology, Research, Telemedicine, Virtual Medicine, Manufacturing, Other Health, Apps, Applications, Oncology, Medical Devices, Health Technology, Hospitals, Biometrics, Cardiology, Other Technology, Biotechnology, Software, Health, Science, Electronic Design Automation, PRISM, Teaching hospital, Biology, Morphometrics, Artificial intelligence, Ventricular septal defect, ICM, Thorax, Living Brain, Molina Healthcare, Test management, INRIA, Cerebral atrophy, Foresight, Medicine, Cancer, Algorithm, Risk, Dravet syndrome, Diagnosis, Cardiovascular disease, System, Cardiac arrest, Epilepsy, SAFIR, Alzheimer's disease, Safety, Cognition, CHU, Metabolism, Neurology, Dassault Group, Public, Artificiality, IHU, Hypoplastic left heart syndrome, Mortality, Patient, EEG, Partnership, Consciousness, Ecosystem, Digital, Vascular dementia, PEPR, Biomarker, Medical imaging

MEDITWIN will offer virtual twins for medical practice, helping to improve the quality of care for safer, more accessible healthcare for all.

Key Points: 
  • MEDITWIN will offer virtual twins for medical practice, helping to improve the quality of care for safer, more accessible healthcare for all.
  • The MEDITWIN project will offer personalized virtual twins of organs, metabolism and cancer, for better diagnosis and treatment.
  • Seven new medical practices will be developed from the virtual twins, in neurology, cardiology and oncology.
  • The MEDITWIN public-private alliance is a major step forward, mobilizing the best of medicine, science and technology to serve future healthcare.

Nearly 100 Physicians from MemorialCare's Long Beach Medical Center, Miller Children's & Women's Hospital Long Beach Recognized by Leading Doctor's Report

Retrieved on: 
Wednesday, January 3, 2024
Otorhinolaryngology, General surgery, Urology, Cardiology, Thorax, Long Beach Medical Center, Physician, Elective surgery, Rheumatology, Pediatrics, Professional, Endocrinology, Gastroenterology, Ophthalmology, Neurology, Patient, Nursing

LONG BEACH, Calif., Jan. 3, 2024 /PRNewswire/ -- MemorialCare's Long Beach Medical Center and Miller Children's & Women's Hospital Long Beach had 86 physicians named Super Doctors and 11 as Rising Stars by the 2023 Southern California Super Doctors & Rising Stars report The Southern California Super Doctors report lists the most outstanding doctors for more than 40 medical specialties, most of whom are in the top 5% of physicians.

Key Points: 
  • LONG BEACH, Calif., Jan. 3, 2024 /PRNewswire/ -- MemorialCare's Long Beach Medical Center and Miller Children's & Women's Hospital Long Beach had 86 physicians named Super Doctors and 11 as Rising Stars by the 2023 Southern California Super Doctors & Rising Stars report The Southern California Super Doctors report lists the most outstanding doctors for more than 40 medical specialties, most of whom are in the top 5% of physicians.
  • The 2023 Southern California Super Doctors report recognizes the top five percent of active doctors in Los Angeles County with two lists: Super Doctors 2023 and Rising Stars.
  • "Having our physicians listed in the Super Doctors and Rising Stars reports highlight the professionalism of our physicians who have attained a high degree of peer recognition and professional achievement," says Joe Kim, M.D., chief medical officer, MemorialCare Long Beach Medical Center.
  • "Our physicians consistently offer exceptional, quality-driven, family-centered care to our patients and families," says Graham Tse, M.D., chief medical officer, MemorialCare Miller Children's & Women's Hospital Long Beach.

Biodesix Enhances Access to Nodify Lung® Testing with Launch of New Blood Draw Method

Retrieved on: 
Tuesday, November 14, 2023
Science, Biotechnology, Research, Oncology, General Health, Health, Medical Devices, Other Health, NYS, Risk, Collection, Patient, FDA, Laboratory, Phlebotomy, Thorax, Blood, Cancer, Physician, Medical device

Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, announced today the validation and launch of a new method of collecting blood specimens for Nodify Lung Nodule Risk Assessment testing.

Key Points: 
  • Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, announced today the validation and launch of a new method of collecting blood specimens for Nodify Lung Nodule Risk Assessment testing.
  • The method uses the FDA-cleared Tasso+™ device, a single-use blood lancing device intended for obtaining capillary whole blood samples from a patient’s upper arm.
  • Blood-based Nodify Lung testing, comprised of the Nodify CDT® and Nodify XL2® tests, addresses a significant unmet need by assessing the risk of cancer in patients with lung nodules.
  • Biodesix offers a range of venous blood draw services, including an extensive network of mobile phlebotomists and independent laboratories.

Hoag's Cardiothoracic Surgery Team Earns Highest Distinction in Three Surgical Areas

Retrieved on: 
Wednesday, November 29, 2023
Society of Thoracic Surgeons, American Heart Association, STS, Patient, Blue Shield of California, Aortic stenosis, Heart failure, Thorax, Blue, Star, News, Isolation, Emergency medical services, AVR, Hospital, CABG, Elaine, Pharmaceutical industry, Society

NEWPORT BEACH, Calif., Nov. 29, 2023 /PRNewswire/ -- Hoag's Jeffrey M. Carlton Heart and Vascular Institute has earned the highest distinction possible, a three-star rating out of three stars, from the Society of Thoracic Surgeons (STS) for three categories of surgery - isolated aortic valve replacement (AVR), isolated mitral valve replacement and repair (MVRR) and isolated coronary artery bypass grafting (CABG).

Key Points: 
  • The cardiac surgery performance of Hoag is in the highest quality tier in the current analysis timeframe from July 2020 through June 2023.
  • Fewer than 2.6% of hospitals nationwide receive a three-star rating for isolated aortic valve replacement.
  • "We are honored by the national recognition for Hoag's Cardiovascular Surgery Program in the highest category for quality and successful outcomes," said Robert T. Braithwaite, Hoag president and CEO.
  • Hoag's cardiac surgery team is led by Anthony Caffarelli, M.D., the Newkirk Family Endowed Chair in Aortic Care, director of Hoag Cardiac Surgery and director of the Elaine & Robert Matranga Aortic Center, as well as esteemed cardiac surgery colleagues Asad Shah, M.D., co-director of Hoag Cardiac Surgery, and Timothy Lee, M.D.

AI Innovation for automated Detection and Classification of osteoporotic Fractures of the Spine in CT Scans - ImageBiopsy Lab launches IB Lab FLAMINGO

Retrieved on: 
Wednesday, November 29, 2023
Osteoporosis, RSNA, UCB, Gold, Abdomen, Spine, Bone fracture, Vertebral compression fracture, Patient, Orthopedic surgery, Radiation exposure, MSK, Medical Affairs Bureau, Fracture, Risk assessment, ZOO, Diagnosis, VFS, Partnership, Thorax, Pain, Hospital, AI, Physician, Quality of life, Dentistry, Medical imaging, Dietary supplement

IB Lab FLAMINGO analyzes any CT images of the upper extremities (thorax, abdomen) that include the spine.

Key Points: 
  • IB Lab FLAMINGO analyzes any CT images of the upper extremities (thorax, abdomen) that include the spine.
  • Developed by UCB , a global biopharmaceutical company, IB Lab FLAMINGO is integrated into ImageBiopsy Lab 's ZOO MSK platform, targeting hospitals to reduce overlooked spinal fractures and support early diagnosis and treatment of osteoporosis.
  • VIENNA, Nov. 29, 2023 /PRNewswire/ -- ImageBiopsy Lab, a pioneer in medical imaging, introduces IB Lab FLAMINGO at this year's RSNA conference.
  • Utilizing the gold standard Genant classification, IB Lab FLAMINGO highlights relevant fractures and empowers proactive treatment for healthcare professionals.

AI Innovation for automated Detection and Classification of osteoporotic Fractures of the Spine in CT Scans - ImageBiopsy Lab launches IB Lab FLAMINGO

Retrieved on: 
Wednesday, November 29, 2023
Osteoporosis, RSNA, UCB, Gold, Abdomen, Spine, Bone fracture, Vertebral compression fracture, Patient, Orthopedic surgery, Radiation exposure, MSK, Medical Affairs Bureau, Fracture, Risk assessment, ZOO, Diagnosis, VFS, Partnership, Thorax, Pain, Hospital, AI, Physician, Quality of life, Dentistry, Medical imaging, Dietary supplement

IB Lab FLAMINGO analyzes any CT images of the upper extremities (thorax, abdomen) that include the spine.

Key Points: 
  • IB Lab FLAMINGO analyzes any CT images of the upper extremities (thorax, abdomen) that include the spine.
  • Developed by UCB , a global biopharmaceutical company, IB Lab FLAMINGO is integrated into ImageBiopsy Lab 's ZOO MSK platform, targeting hospitals to reduce overlooked spinal fractures and support early diagnosis and treatment of osteoporosis.
  • VIENNA, Nov. 29, 2023 /PRNewswire/ -- ImageBiopsy Lab, a pioneer in medical imaging, introduces IB Lab FLAMINGO at this year's RSNA conference.
  • Utilizing the gold standard Genant classification, IB Lab FLAMINGO highlights relevant fractures and empowers proactive treatment for healthcare professionals.

As Lung Cancer Rates Continue to Rise in Never-Smokers, Theator Expands Surgical Solution into Thoracic Surgery

Retrieved on: 
Thursday, November 16, 2023
PALO, Pulmonology, Esophagus, Surgeon, Most, Patient, Anesthesiology, Thorax, Cardiothoracic surgery, Lung cancer, Oncology, Hospital, AI, Elective surgery, Health, Dentistry, Medical device

PALO ALTO, Calif., Nov. 16, 2023 /PRNewswire/ -- Theator, a health-technology company that leverages advanced AI and computer vision technology to help surgeons and hospitals improve the quality of patient care, today announced that it will be expanding its Surgical Intelligence Platform into the field of thoracic surgery.  Despite there being over 530,000 thoracic procedures conducted in the US each year, the surgical specialty is facing a major deficit of cardiothoracic surgeons. With lung cancer continuing to be on the rise in never-smokers, Theator's award-winning technology will help hospitals meet the growing demand for minimally invasive thoracic surgeries by providing surgeons in the OR with the actionable insights they need to not only address but also up-level patient care across the board.

Key Points: 
  • Despite there being over 530,000 thoracic procedures conducted in the US each year, the surgical specialty is facing a major deficit of cardiothoracic surgeons.
  • "At Theator, we are focused on generating actionable insights to positively impact patient outcomes and improve the quality of patient care," said Dr. Tamir Wolf, co-founder and CEO of Theator.
  • "Currently, there are limited ways for surgeons to access actionable and reliable evaluations of thoracic surgical performance," said Dr. Matthew Ninan, Director of Thoracic Surgery at HCA Florida Healthcare West Division.
  • For more information about Theator's Surgical Intelligence Platform and its expansion into the field of thoracic, please visit www.theator.io .

Capital Health Surgeon Becomes First Black Woman to Lead Regional Surgical Society

Retrieved on: 
Monday, October 30, 2023
Female, Woman, Education, Health, Surgeon, Cardiothoracic surgery, Capital Health Regional Medical Center, Equity, Research, Multimedia, Hopewell, Capital Health, Diversity, Society, Cancer, Deborah Heart and Lung Center, Dentistry, Medical device, Thorax

HOPEWELL, N.J., Oct. 30, 2023 /PRNewswire/ -- Dr. Africa Wallace, director of Thoracic Surgery at Capital Health, was recently named the president of the Eastern Cardiothoracic Surgical Society (ECTSS).

Key Points: 
  • HOPEWELL, N.J., Oct. 30, 2023 /PRNewswire/ -- Dr. Africa Wallace, director of Thoracic Surgery at Capital Health, was recently named the president of the Eastern Cardiothoracic Surgical Society (ECTSS).
  • Dr. Wallace is the first black female president for ECTSS and the first of any cardiothoracic surgery society.
  • "The Eastern Cardiothoracic Surgical Society works to advance the highest standards of excellence in patient care through education, research, and surgical training programs," said Dr. Wallace.
  • "I'm excited to lead an organization that aligns with my personal commitment to quality, diversity and inclusion in health care and Capital Health's mission of improving the health and well-being of the communities it serves."

HALO Precision Diagnostics Collaborating with Bayer to Advance Contrast-Enhanced MRI

Retrieved on: 
Tuesday, October 17, 2023
Biotechnology, Health, Radiology, Clinical Trials, Oncology, Cardiovascular disease, Partnership, Pharmacokinetics, Abdomen, Breast cancer, Pelvis, Central nervous system, Ageing, Safety, Thorax, R, Extremities, Neck, Head, MRI, Prostate cancer, Patient, HALO, Medical device, Medical imaging, Bayer

HALO Precision Diagnostics (“HALO”), a leader in early disease detection using precision diagnostics, today announced a collaboration with Bayer, ​​a global leader in radiology, to join QUANTI, Bayer’s Phase III clinical development program for gadoquatrane.

Key Points: 
  • HALO Precision Diagnostics (“HALO”), a leader in early disease detection using precision diagnostics, today announced a collaboration with Bayer, ​​a global leader in radiology, to join QUANTI, Bayer’s Phase III clinical development program for gadoquatrane.
  • Bayer initiated the QUANTI studies to evaluate the safety and efficacy of gadoquatrane, an investigational gadolinium-based contrast agent, in MRI.
  • Contrast-enhanced MRI plays a key role in the healthcare continuum, providing a radiation-free imaging method to obtain detailed images of the body.
  • “Our partnership with Bayer is the latest example of HALO leading the way when it comes to advancements supporting early disease detection,” said Bernadette Greenwood, chief research officer, HALO.